Literature DB >> 4980931

Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions.

A J Levi, Z Gatmaitan, I M Arias.   

Abstract

Two hepatic cytoplasmic protein fractions, designated Y and Z, which bind sulfobromophthalein (BSP), bilirubin, and other organic anions, have been separated by G75 Sephadex gel filtration. The physiologic role of these protein fractions has been investigated. They are present in the 110,000 g supernatant fraction from the livers of all the species tested (rats, mice, guinea pigs, Rhesus monkeys, sheep, and man). Tissues which do not preferentially extract BSP or bilirubin from plasma do not contain these fractions, with the exception of small intestinal mucosa which contains Z. Anion binding by Y and Z fractions is not due to contamination with albumin. These fractions are responsible for the cytoplasmic localization of bilirubin in Gunn rats, and the fractions bind bilirubin, BSP, or indocyanine green (ICG), whether given in vivo or added in vitro to liver supernate from normal rats. Flavaspidic acid-N-methylglucaminate, bunamiodyl, and iodipamide, drugs known to interfere with the hepatic uptake mechanism, compete with bilirubin and BSP for binding to Z. These proteins appear to be important in the transfer of organic anions from plasma into the liver and provide a tool for the investigation of hepatic uptake mechanisms.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4980931      PMCID: PMC297469          DOI: 10.1172/JCI106182

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Altered sulfobromophthalein metabolism in man induced by the antifungal agent X-5079C.

Authors:  V T ANDRIOLE; J P UTZ; S M SABESIN
Journal:  Am Rev Respir Dis       Date:  1961-10

2.  HEPATIC TRANSPORT OF BILIRUBIN.

Authors:  B H BILLING; Q MAGGIORE; M A CARTTER
Journal:  Ann N Y Acad Sci       Date:  1963-12-30       Impact factor: 5.691

3.  Solubility of bilirubin in aqueous solutions.

Authors:  R C BURNSTINE; R SCHMID
Journal:  Proc Soc Exp Biol Med       Date:  1962-02

4.  The plasma removal on indocyanine green and sulfobromophthalein: effect of dosage and blocking agents.

Authors:  D B HUNTON; J L BOLLMAN; H N HOFFMAN
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

5.  Mercaptide conjugation in the uptake and secretion of sulfobromophthalein.

Authors:  J R PHILP; G M GRODSKY; J V CARBONE
Journal:  Am J Physiol       Date:  1961-03

6.  Entero-hepatic circulation of bromsulphalein. I. Studies on man with special reference to the clinical BSP test.

Authors:  S H LORBER; H SHAY
Journal:  Gastroenterology       Date:  1952-02       Impact factor: 22.682

7.  [Excretion of non-conjugated bilirubin in rat bile. Changes in such excretion caused by novobiocin].

Authors:  P Berthelot; R Fauvert
Journal:  Rev Fr Etud Clin Biol       Date:  1967 Aug-Sep

8.  Binding of sulfobromophthalein sodium (BSP) and other organic anions by isolated hepatic cell plasma membranes in vitro.

Authors:  C E Cornelius; J Ben-Ezzer; I M Arias
Journal:  Proc Soc Exp Biol Med       Date:  1967-02

9.  Hepatic intracellular distribution of tritium-labeled unconjugated and conjugated bilirubin in normal and Gunn rats.

Authors:  L H Bernstein; J B Ezzer; L Gartner; I M Arias
Journal:  J Clin Invest       Date:  1966-07       Impact factor: 14.808

10.  THE HEPATIC UPTAKE AND EXCRETION OF SULFOBROMOPHTHALEIN AND BILIRUBIN.

Authors:  C A GORESKY
Journal:  Can Med Assoc J       Date:  1965-04-17       Impact factor: 8.262

View more
  132 in total

1.  Hepatocellular uptake of taurocholate in the dog.

Authors:  S Erlinger
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

2.  Evolution of the family of intracellular lipid binding proteins in vertebrates.

Authors:  Frank G Schaap; Ger J van der Vusse; Jan F C Glatz
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

3.  Kinetic analysis of the dose-dependent hepatic handling of 1-anilino-8-naphthalene sulfonate in rats.

Authors:  Y B Chung; S Miyauchi; Y Sugiyama; H Harashima; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1990-08

Review 4.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.

Authors:  D K Meijer; P van der Sluijs
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

6.  Intrahepatic cholestasis as a side-effect of drug therapy.

Authors:  G Feuer; M S Dhami
Journal:  Can Fam Physician       Date:  1982-07       Impact factor: 3.275

7.  Hepatic clearance of adenosine 3:5-cyclic monophosphate from plasma in the rat.

Authors:  R C Strange; I W Robb
Journal:  Biochem J       Date:  1975-02       Impact factor: 3.857

Review 8.  Nomenclature of fatty acid-binding proteins.

Authors:  J F Glatz; G J van der Vusse
Journal:  Mol Cell Biochem       Date:  1990 Oct 15-Nov 8       Impact factor: 3.396

Review 9.  Cellular fatty acid-binding proteins: current concepts and future directions.

Authors:  J F Glatz; G J van der Vusse
Journal:  Mol Cell Biochem       Date:  1990 Oct 15-Nov 8       Impact factor: 3.396

10.  The interactions of haem with ligandin and aminoazo-dye-binding protein A.

Authors:  E Tipping; B Ketterer; L Christodoulides; G Enderby
Journal:  Biochem J       Date:  1976-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.